{"Bevantolol":{"RelatedTo":"Beta-1 adrenergic receptor","Synonym":["1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol","Bevantololum (inn-latin)"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB01295","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB01295","Definition":"Bevantolol is a beta-1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension. Mechanism of Action Animal experiments confirm both agonist and antagonist effects on alpha-receptors, in addition to antagonist activity at beta-1 receptors. Pharmacology: Bevantolol is a beta-1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension. Mechanism of action: Animal experiments confirm both agonist and antagonist effects on alpha-receptors, in addition to antagonist activity at beta-1 receptors. Drug type: Approved. Small Molecule. Drug category: Adrenergic beta-Antagonists. Antihypertensive Agents. Calcium Channel Blockers"}}